Cargando…

Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid

Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and ranges from isolated steatosis to NASH. To determine whether circulating fatty acids could serve as diagnostic markers of NAFLD severity and whether specific fatty acids could contribute to the pathogenesis of NAS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Wonbeak, Gjuka, Donjeta, Stevenson, Heather L., Song, Xiaoling, Shen, Hong, Yoo, Suk Young, Wang, Jing, Fallon, Michael, Ioannou, George N., Harrison, Stephen A., Beretta, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731750/ https://www.ncbi.nlm.nih.gov/pubmed/29244873 http://dx.doi.org/10.1371/journal.pone.0189965

Ejemplares similares

Is Plasma Pentadecanoic Acid a Reasonable Biomarker of Dairy Consumption?
por: Djoussé, Luc
Publicado: (2013)

Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model
por: Li, Hua, et al.
Publicado: (2019)

Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential?
por: Venn-Watson, Stephanie, et al.
Publicado: (2020)

Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds
por: Venn-Watson, Stephanie, et al.
Publicado: (2023)

A Review of Odd-Chain Fatty Acid Metabolism and the Role of Pentadecanoic Acid (C15:0) and Heptadecanoic Acid (C17:0) in Health and Disease
por: Jenkins, Benjamin, et al.
Publicado: (2015)

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014)

Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid
por: Wei, Wenchao, et al.
Publicado: (2023)

Plasma phospholipid pentadecanoic acid, EPA, and DHA, and the frequency of dairy and fish product intake in young children
por: Lund-Blix, Nicolai A., et al.
Publicado: (2016)

Pentadecanoic acid promotes basal and insulin-stimulated glucose uptake in C2C12 myotubes
por: Fu, Wen-Cheng, et al.
Publicado: (2021)

Heptadecanoic acid and pentadecanoic acid crosstalk with fecal-derived gut microbiota are potential non-invasive biomarkers for chronic atrophic gastritis
por: Gai, Xiao, et al.
Publicado: (2023)

Evaluation of radiation-induced myocardial damage using iodine-123 β-methyl-iodophenyl pentadecanoic acid scintigraphy
por: Umezawa, Rei, et al.
Publicado: (2013)

Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022)

Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling
por: To, Ngoc Bao, et al.
Publicado: (2020)

Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems
por: Venn-Watson, Stephanie K., et al.
Publicado: (2022)

Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis
por: Stallings, Virginia A., et al.
Publicado: (2013)

Methods of calculating (123)I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy
por: Chen, Zhuoqing, et al.
Publicado: (2022)

Dietary fatty acids and risk of non-alcoholic steatohepatitis: A national study in the United States
por: Lu, Xiao-Ting, et al.
Publicado: (2022)

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
por: Eguchi, Yuichiro, et al.
Publicado: (2020)

Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice
por: Park, Han-Sol, et al.
Publicado: (2016)

Dietary Long-Chain Fatty Acids Accelerate Metabolic Dysfunction in Guinea Pigs with Non-Alcoholic Steatohepatitis
por: Pedersen, Kamilla, et al.
Publicado: (2023)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Gillard, Justine, et al.
Publicado: (2021)

Identification of a Fatty Acid for Diagnosing Non-Alcoholic Steatohepatitis in Patients with Severe Obesity Undergoing Metabolic Surgery
por: Takahashi, Naoto, et al.
Publicado: (2022)

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022)

The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
por: Xiang, Zun, et al.
Publicado: (2013)

The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis
por: Lee, Su Jin, et al.
Publicado: (2014)

Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
por: Takai, Atsuko, et al.
Publicado: (2020)

Reduction of Polyunsaturated Fatty Acids with Tumor Progression in a Lean Non-Alcoholic Steatohepatitis-Associated Hepatocellular Carcinoma Mouse Model
por: Vlock, Elizabeth M, et al.
Publicado: (2020)

Nitro-oleic acid as a new drug candidate for non-alcoholic steatohepatitis
por: Yang, Rui-Xu, et al.
Publicado: (2019)

Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis
por: Yu, Amy, et al.
Publicado: (2022)

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States
por: Siddique, Osama, et al.
Publicado: (2017)

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2016)

Lonicera caerulea Extract Attenuates Non-Alcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Hepatocytes and in High Fat Diet-Fed Mice
por: Park, Miey, et al.
Publicado: (2019)

Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology
por: Akter, Sharmin
Publicado: (2022)

Increasing Dietary Medium-Chain Fatty Acid Ratio Mitigates High-fat Diet-Induced Non-Alcoholic Steatohepatitis by Regulating Autophagy
por: Wang, Mu-En, et al.
Publicado: (2017)

High-trans fatty acid and high-sugar diets can cause mice with non-alcoholic steatohepatitis with liver fibrosis and potential pathogenesis
por: Xin, Xin, et al.
Publicado: (2020)

Effectiveness of Iodine-123 β-methyl-P-iodophenyl-pentadecanoic acid (BMIPP) Myocardial Scintigraphy for Cancer Therapeutics-Related Cardiac Dysfunction (CTRCD) in Breast Cancer Patients
por: Harada, Yuko, et al.
Publicado: (2022)

Engineering Saccharomyces cerevisiae for Efficient Biosynthesis of Fatty Alcohols Based on Enhanced Supply of Free Fatty Acids
por: Tang, Xiaoling, et al.
Publicado: (2017)

Omega-3 Polyunsaturated Fatty Acids Prevent Nonalcoholic Steatohepatitis (NASH) and Stimulate Adipogenesis
por: Antraco, Vitor Jacó, et al.
Publicado: (2021)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Iravani, Farzaneh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_emivceriguiprghat98s1a3o67